A Clinical Study to Evaluate the Efficacy and Safety of Envafolimab Combined With Cetuxima-βand mFOLFOX6 in Patients With MSS, RAS/BRAF Wild-Type Metastatic Colorectal Cancer (mCRC)

NCT06959693 · clinicaltrials.gov ↗

PHASE2,PHASE3

Phase

NOT_YET_RECRUITING

Status

590

Enrollment

OTHER

Sponsor class

Conditions

Metastatic Colorectal Cancer (CRC)

Interventions

DRUG: Cetuxima-β
DRUG: Envafolimab
DRUG: mFOLFOX6

Sponsor

Sun Yat-sen University